Innogene Kalbiotech Pte. Ltd: Clinical Trials

10 trials sponsored by Innogene Kalbiotech Pte. Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown. 7 Phase 3, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Unknown 3
Phase 22Completed 2
Phase 41Completed 1

Follow Innogene Kalbiotech Pte. Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
RTXM83, Mabthera - Diffuse Large B-cell Lymphoma
Phase 3CompletedmAbxience Research S.L.2722013-05-012019-09-26
Immunotherapy With Racotumomab in Advanced Lung Cancer
Racotumomab, Best Support Treatment - NSCLC, Lung Cancer, Non-small Cell
Phase 3UnknownRecombio SL10822010-09-012016-07-29
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
0.5M Sodium lactate, Hartmann's solution - Acute Heart Failure
Phase 2CompletedNepean Blue Mountains Local Health District412009-12-012013-11-13
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
Nimotuzumab, Placebo - Carcinoma, Squamous Cell of Head and Neck
Phase 3UnknownNational Cancer Centre, Singapore7102009-08-132024-01-09
Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
Hyperosmolar sodium lactate, Ringer's lactate - Hemorrhagic Shock
Phase 3CompletedInnogene Kalbiotech Pte. Ltd712009-07-012011-09-13
Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
Hypertonic sodium lactate, 6% Hydroxy Ethyl Starch - Coronary Heart Disease
Phase 4CompletedInnogene Kalbiotech Pte. Ltd1002008-07-012012-08-01
Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
Hypertonic sodium lactate, Ringer's lactate - Dengue Shock Syndrome
Phase 3UnknownInnogene Kalbiotech Pte. Ltd502008-05-012009-08-28
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
Nimotuzumab, Cisplatin, Radiation - Head and Neck Cancer
Phase 2CompletedNational Cancer Centre, Singapore322008-04-282023-02-28
The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients
Hypertonic lactate, Ringer's lactate - Low Cardiac Output
Phase 3CompletedInnogene Kalbiotech Pte. Ltd662005-07-012007-09-14
Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats
Hypertonic lactate, Ringer's lactate - Low Cardiac Output
Phase 3CompletedInnogene Kalbiotech Pte. Ltd2302002-03-012007-09-14

Conditions studied

Cardiac Output, Low (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Coronary Disease (1)  ·  Dengue (1)  ·  Head and Neck Neoplasms (1)  ·  Heart Diseases (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Severe Dengue (1)  ·  Shock, Hemorrhagic (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Wounds and Injuries (1)

Interventions

Ringer's Lactate (5)  ·  nimotuzumab (2)  ·  Cisplatin (1)  ·  HES 130-0.4 (1)  ·  Radiation (1)  ·  Rituximab (1)  ·  Sodium Lactate (1)  ·  racotumomab (1)

Countries

Indonesia (8)  ·  Philippines (3)  ·  Singapore (3)  ·  Argentina (2)  ·  Australia (2)  ·  Brazil (2)  ·  Cuba (2)  ·  India (2)  ·  Malaysia (2)  ·  South Africa (2)  ·  Thailand (2)  ·  Colombia (1)  ·  Egypt (1)  ·  Iran (1)  ·  Mexico (1)

Top investigators

Xavier Leverve, MD, PhD (3)  ·  Cindy E Boom, PhD, MD (1)  ·  Dadang H Somasetia, SpA(K), MKes (1)  ·  Iqbal Mustafa, MD (1)  ·  K C Soo, Prof (1)  ·  Kiki Lukman, SpBD(K) (1)  ·  Marek Nalos, MD (1)  ·  Roberto Gomez, M.D. (1)  ·  Wan-Teck Lim, MD (1)

Results publications

PMID 24666826, PMID 25189175